
About WHAYN
WHAYN is a Healthcare company based in Gurugram (India) founded in 2011. Platform for healthcare product manufacturing, sourcing, and supply chain support. It operates on a B2B Marketplace and Contract Manufacturing model in Healthcare and Industrial Goods & Manufacturing sectors. Its Indian entity Jindal Biotech Private Limited reported revenue of βΉ2.33 Cr. WHAYN offers products and services including Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing. Its focus areas include Pharmaceuticals, Supply Chain, White Label Production and Medical Devices. Its competitors include Medikabazaar and Aknamed; 2 of its 2 listed competitors have raised funding.
Company details
WHAYN is a platform that offers end-to-end solutions for developing, manufacturing, and complying with medical, pharmaceutical, and surgical products. It connects buyers and suppliers, providing features like batch tracking and regulatory assistance. Based in Menlo Park, USA, it serves brands and retailers worldwide, ensuring quality control and efficient scaling across various categories such as cotton products and wound care.
- Headquarters Gurugram, India
- SectorsHealthcareIndustrial Goods & Manufacturing
- Website whayn.com
- Social LinkedIn X Facebook
- Legal Name Jindal Biotech Private Limited
- Date of Incorporation 28 Jun, 2011
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹2.33 Cr
FY 2024 · -70% YoY
- Net Loss-₹16.1 Lakh
FY 2024 · -7% margin
- EBITDA₹2.1 Lakh
FY 2024 · 1% margin
Associated legal entities of WHAYN
WHAYN operates through Jindal Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jindal Biotech Private Limited CIN U74140DL2011PTC221563 | Active | 28 Jun 2011 | New Delhi, Delhi | ₹2.3 Cr | 2 | View details |
Products & Services of WHAYN
WHAYN offers a comprehensive portfolio of products and services, including Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing.
Designs and produces custom products for clients.
Develops original products for manufacturing.
Manufactures generic products under client brands.
Board of directors of Jindal Biotech Private Limited (WHAYN)
Jindal Biotech Private Limited is the primary company behind WHAYN. The board of Jindal Biotech Private Limited currently have 2 directors; the longest-serving is Rakesh Kumar Jindal, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rakesh Kumar Jindal DIN 03285251 | Director | 28 Jun 2011 | 15 yrs 4 mo | Jindal Biotech Private Limited |
| Krishan Gopal DIN 03285287 | Director | 16 Aug 2022 | 4 yrs 3 mo | Jindal Biotech Private Limited |
Financials of WHAYN
Figures of Jindal Biotech Private Limited, the primary company behind WHAYN, for FY 2024. Revenue was ₹2.33 Cr (-70% year on year). Net loss was -₹16.1 Lakh (-7% margin). EBITDA was ₹2.1 Lakh (1% margin). Revenue has grown at a compounded annual rate of -34% over three years and -13% over five years.
- ₹2.33 CrRevenue · FY 2024 · -70% YoY
- -₹16.1 LakhNet loss · -7% margin
- ₹2.1 LakhEBITDA · 1% margin
- ₹25 LakhPaid-up capital
- -34%Revenue CAGR, 3 years
- -13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jindal Biotech Private Limited are on its company page.
Detailed financial statements for WHAYN
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of WHAYN
WHAYN has 2 listed competitors in our database, 2 of them funded. They include Medikabazaar and Aknamed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medikabazaar.com | 2014 | Mumbai, India | $184.89M | 547 | Online marketplace for medical supplies, equipment, and devices catering to healthcare providers | |
| aknamed.com | 2018 | Gurugram, India | $21.85M | 246 | Cloud and AI-based material management software for hospitals is offered. |
Detailed competitors of WHAYN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about WHAYN
WHAYN was founded in 2011.
WHAYN is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
The primary company behind WHAYN, Jindal Biotech Private Limited, reported revenue of βΉ2.33 Cr for FY 2024, down 70% year on year.
WHAYN is a platform that offers end-to-end solutions for developing, manufacturing, and complying with medical, pharmaceutical, and surgical products. It connects buyers and suppliers, providing features like batch tracking and regulatory assistance. Based in Menlo Park, USA, it serves brands and retailers worldwide, ensuring quality control and efficient scaling across various categories such as cotton products and wound care.
WHAYN's top competitors include Medikabazaar and Aknamed.
WHAYN offers Contract Manufacturing, Product Design and Development, and White Labelled Manufacturing.
WHAYN operates through Jindal Biotech Private Limited.
The legal entities of WHAYN currently have 2 directors, including Rakesh Kumar Jindal, Krishan Gopal.